Journal
CURRENT OPINION IN UROLOGY
Volume 14, Issue 6, Pages 329-334Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00042307-200411000-00006
Keywords
benign prostatic hyperplasia; botulinum toxin; detrusor external sphincter dyssynergia; dysfunctional voiding; overactive bladder
Categories
Ask authors/readers for more resources
Bladder injection of botulinum toxin is not yet an approved treatment for lower urinary tract dysfunction. Nevertheless, available data suggest that in the near future the toxin will become a standard therapeutic option in incontinent patients with neurogenic and non-neurogenic forms of overactive bladder, who do not respond to or do not tolerate anticholinergic medication. In addition, it might be expected that urethral botulinum toxin injections improve bladder emptying in patients with dysfunctional voiding problems besides detrusor external sphincter dyssynergia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available